CAS: 4704-94-3; 2-(Hydroxymethyl)Propane-1,3-Diol

该化合物是一种无色,粘性液体,在水和有机溶剂中可溶解,无色,粘性液体,其分子配方为C4H10O3,具有三种氢氧基(-OH),有助于其反应和形成氢结质的能力;该化合物主要用作聚酯,聚氨酯和其他聚合物合成的构件,使其在涂层,粘合剂和塑料生产中具有价值;该化合物的氢氧化物组增强功能,使其能够参与各种化学反应,包括酯化和化;此外,2-(Hydroxyphy-thy)-1,1-丙烷基醇组具有低毒性,被认为安全用于许多用途,包括化妆品和个人护理产品;它与其他材料的稳定性和兼容性进一步提高其在工业配方中的效用;

结构式图片

相似化合物

117087-18-0 6279-86-3 80370-42-9

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号555-43-1 三硬脂酸甘油酯 | CAS号555-44-2 (三)棕榈酸甘油酯 | CAS号122-32-7 甘油三油酸酯 | CAS号40364-80-5 3-hydroxy-2-(hy... | CAS号465540-17-4 [2-(4-methoxyph... | CAS号113967-50-3 benzoic acid,[3... | CAS号6279-86-3 甲烷三羧酸三乙酯 | CAS号50-00-0 甲醛 | CAS号107-02-8 丙烯醛 | CAS号75-07-0 乙醛 | CAS号4728-12-5 (2,2-二甲基-1,3-二恶... | CAS号113967-52-5 [3-hydroxy-2-(h... | CAS号465540-17-4 [2-(4-methoxyph... | CAS号4728-07-8 1,3-dioxan-5-yl... | CAS号60111-68-4 1,3-dibromo-2-(...

合成工艺路线路线简述

    (2-(4-Methoxyphenyl)-1,3-Dioxan-5-yl)Methanol置于水,Selectfluor体系中,用 乙腈 作为反应溶剂,化学反应 5.0H,以90%的收率获得产物2-羟甲基-1,3-丙二醇
    参考文献:通过selectfluor™裂解对甲氧基亚苄基(pmp),四氢吡喃基(thp)和1,3-二硫杂环丁烷保护基的有效方法
    标题:通过selectfluor™裂解对甲氧基亚苄基(pmp),四氢吡喃基(thp)和1,3-二硫杂环丁烷保护基的有效方法
    摘要:已开发出一种新的有效方法,用于用selectfluor™裂解pmp,Thp和1,3-二硫杂环丁烷保护基.
    DOI:10.1016/s0040-4039(02)00740-2

    海关参考信息

    专利信息


    专利号:US-7122304-B2
    优先权日:1997-05-12
    标 题:Methods for the storage and synthesis of nucleic acids using a solid support
    发明人:GOLDSBOROUGH MINDY D; FOX DONNA K
    权利人:WHATMAN INC
    摘要:The invention relates to storage of nucleic acid (particularly mRNA) on a solid support and to using such nucleic acid in nucleic acid synthesis or amplification reactions. In a preferred aspect, the invention provides synthesis of cDNA and cDNA libraries.

    专利号:US-8618281-B2
    优先权日:2006-01-03
    标 题 :Geometric synthesis of porphyrin rods
    发明人:LINDSEY JONATHAN S; YU LIANHE; THAMYONGKIT PATCHANITA; BHISE ANIL D
    权利人:LINDSEY JONATHAN S; YU LIANHE; THAMYONGKIT PATCHANITA; BHISE ANIL D; UNIV NORTH CAROLINA STATE
    摘要:A method of making a compound of Formula I′ n ncomprises reacting a compound of the formula DLCHO, with a compound of the formulan n nto produce the compound of Formula I′. Methods of using the compounds are also described, particularly as intermediates for the synthesis of porphyrin rods, which porphyrin rods are in turn useful for (among other things) the production of molecular memory devices.

    专利号:US-10919904-B2
    优先权日:2016-08-17
    标 题 :Northern-southern route to synthesis of bacteriochlorins
    发明人:LIU YIZHOU; LINDSEY JONATHAN S; ALLU SRINIVASA RAO; FUJITA HIKARU
    权利人:UNIV NORTH CAROLINA STATE
    摘要:Described herein are chlorins, bacteriochlorins, methods and intermediates for the synthesis of bacteriochlorins, and methods of using such bacteriochlorins for, among other things, diagnostic and therapeutic purposes such as luminescent compounds in flow cytometry, and as active agents in photodynamic therapy (PDT).

    专利号:US-11034664-B1
    优先权日:2020-05-11
    标题 :Synthesis of cyclic carbonate monomers
    发明人:PARK NATHANIEL H; HEDRICK JAMES L; PIUNOVA VICTORIA A; ARRECHEA PEDRO; ERDMANN TIM
    权利人:IBM
    摘要:Techniques regarding the synthesis of cyclic carbonate monomers are provided. For example, one or more embodiments described herein can comprise a method, which can include cyclizing a functionalized diol monomer with N,N′-carbonyldiimidazole, wherein the cyclizing produces a cyclic carbonate monomer and an imidazole carbamate. The method can also include activating the imidazole carbamate with an acid, wherein the activating promotes cyclization of the imidazole carbamate into the cyclic carbonate monomer.

    专利号:US-7211590-B2
    优先权日:2002-08-01
    标 题:Nitrosated proton pump inhibitors, compositions and methods of use
    发明人:FANG XINQIN; GARVEY DAVID S; LETTS L GORDON
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated proton pump inhibitor compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated proton pump inhibitor compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated proton pump inhibitor compound, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated proton pump inhibitor compound, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating gastrointestinal disorders; facilitating ulcer healing; decreasing the recurrence of ulcers; improving gastroprotective properties, anti-Helicobacter pylori properties or antacid properties of proton pump inhibitors; decreasing or reducing the gastrointestinal toxicity associated with the use of nonsteroidal antiinflammatory compounds; treating bacterial infections and/or viral infections.

    专利号:US-9822123-B2
    优先权日:2005-02-18
    标 题 :De novo synthesis of bacteriochlorins
    发明人:KIM HAN-JE; LINDSEY JONATHAN S
    权利人:UNIV NORTH CAROLINA STATE
    摘要:A method of making a bacteriochlorin is carried out by condensing a pair of compounds of Formula II n nto produce the bacteriochlorin, wherein R is an acetal or aldehyde group. The condensing may be carried out in an organic solvent, preferably in the presence of an acid. The bacteriochlorins are useful for a variety of purposes such as active agents in photodynamic therapy, luminescent compounds in flow cytometry, solar cells, light harvesting arrays, and molecular memory devices.
    重庆茂环科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bschem.com/
    电话: 13996103726👤
    📞重庆茂环科技有限公司 ⚠️参考联系方式

    销售电话:13996103726
    邮箱:info@bschem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    重庆亚翔龙生物医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yaxianglong.com
    企业联系电话:023-40812010;0812523👤
    📞重庆亚翔龙生物医药有限公司 ⚠️参考联系方式
    联系人:张小姐
    电话:023-40812010;0812523
    手机:18008345763;17783591035
    传真:023-40720172
    邮箱:QQ:3007199072;3007224121;3007198410;3007198508
    通信地址: 重庆市长寿区晏家街道育才路5号3-1
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:重庆市长寿区晏家街道育才路5号3-1
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海亚毓生物医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yayupharm.com
    企业联系电话:021-54370255👤
    📞上海亚毓生物医药有限公司 ⚠️参考联系方式
    联系人:王经理
    电话:021-54370255
    手机:13862662808
    传真:021-54370255
    邮箱:yayu@yalongchina.net
    通信地址: 上海市金山区金山卫镇秋实路688号
    邮编: 201515
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市金山区金山卫镇秋实路688号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Chie Takasu, Et Al. Treatment With Dimethyl Fumarate Attenuates Calcineurin Inhibitor-Induced Nephrotoxicity. Transplantation. 2015 Jun;99(6):1144-50.

    合成参考文献


    参考文献:10.1007/s10895-015-1681-3
    摘要:Dehbozorgi A, Tashkhourian J, Zare S. Fluorescence Determination of Warfarin Using TGA-capped CdTe Quantum Dots in Human Plasma Samples. Journal of Fluorescence. 2015 Oct 19;25(6):1887–95. doi: 10.1007/s10895-015-1681-3.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知